Sponsor
Pharma sector: Firms to clock 11% sales, EBITDA growth in Q1FY26
Posted
India's pharmaceutical sector is projected to experience an 11% year-on-year growth in sales and EBITDA for Q1 FY26, driven by strong market performance across various regions. The hospital segment is expected to lead with a 17% growth, while diagnostics firms anticipate a 14% sales increase. Government initiatives and investments in R&D further support the industry's optimistic outlook.
Zoeken
Categorieën
- National
- International
- Business
- Technology
- Health
- Onderwijs
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
Nora Fatehi breaks down at Mumbai airport: Watch
Nora Fatehi sparked concern among fans after she was spotted crying at Mumbai airport on Sunday...
Adani NCD issue: Adani Enterprises launches Rs 1,000 crore NCD offer at 9.3% yield, aims to repay debt
Adani Enterprises Ltd (AEL) is launching a public issue of secured non-convertible debentures...
Ibhrahim Ali Khan shares intense look from ‘Sarzameen’
MUMBAI: The upcoming action-thriller Sarzameen, which stars Kajol, Prithviraj Sukumaran, and...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Dutch
